The role of ultrasound in the diagnosis of the coexistence of primary hyperparathyroidism and non-medullary thyroid carcinoma
- PMID: 30658569
- PMCID: PMC6339388
- DOI: 10.1186/s12880-019-0306-8
The role of ultrasound in the diagnosis of the coexistence of primary hyperparathyroidism and non-medullary thyroid carcinoma
Abstract
Background: The coexistence of primary hyperparathyroidism(PHPT) and papillary thyroid cancer(PTC) is a known entity; it is a rare and complicated setting for diagnostic imaging.
Methods: After reviewing clinical data of 112 patients who had been treated for PHPT in our facility between January 2015 and December 2017, we identified 7 non-medullary thyroid carcinoma (NMTC) (6.25%). All of them had taken an ultrasound scan and undergone operation. In addition, we have also reviewed relevant reports from other facilities addressing PHPT and NMTC (Mainly PTC).
Results: The 7 NMTCs were all pathologically confirmed PTC in our study, and they consisted of 6 parathyroid adenomas and 1 parathyroid carcinoma. 1 of the 7 patients had 2 malignant PTC nodules with neck lymph node metastasis, the rest 6 had single-focal PTC. Processing previous report data supported an association between PHPT and PTC, although the coexistence of PHPT and PTC is rare, but it does happen. Ultrasound, as an effective examination, would help screen the simultaneous lesions before operation, thus to avoid second surgery if not observed for both diseases at initial stage.
Conclusions: Ultrasound is a necessary choice for preoperative localization, because it has the ability to simultaneously examine the thyroid and parathyroid lesions.
Keywords: Papillary thyroid carcinoma; Preoperative localization; Primary hyperparathyroidism; Ultrasound.
Conflict of interest statement
Ethics approval and consent to participate
The study was approved by Ethics Committee of Shanghai Sixth People’s Hospital. All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional research committee and the declaration of Helsinki. Formal consent is not required for this type of study.
Consent for publication
Written informed consent was obtained from patients for publication of this article and accompanying images. A copy of the written consent is available for review by Editor-in Chief of this journal.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures

Similar articles
-
Simultaneous intrathyroidal parathyroid adenomas and multifocal papillary thyroid carcinoma in a patient with kidney transplantation: a case report.BMC Nephrol. 2019 Nov 9;20(1):405. doi: 10.1186/s12882-019-1600-y. BMC Nephrol. 2019. PMID: 31706276 Free PMC article.
-
Coincidence of primary hyperparathyroidism and nonmedullary thyroid carcinoma.Horm Metab Res. 2013 Sep;45(9):660-3. doi: 10.1055/s-0033-1345184. Epub 2013 Jun 11. Horm Metab Res. 2013. PMID: 23757116
-
Coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics.BMC Surg. 2019 Jul 16;19(1):94. doi: 10.1186/s12893-019-0556-y. BMC Surg. 2019. PMID: 31311533 Free PMC article.
-
Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: Diagnosis of central and lateral compartment nodal metastases.Eur J Radiol. 2019 Mar;112:14-21. doi: 10.1016/j.ejrad.2019.01.006. Epub 2019 Jan 7. Eur J Radiol. 2019. PMID: 30777203 Review.
-
Papillary Thyroid Carcinoma Incidentally Found in Cervical Lymph Nodes During Neck Dissection for Patients With Tongue Squamous Cell Carcinoma: A 3-Case Report and Literature Review.J Oral Maxillofac Surg. 2018 Nov;76(11):2454.e1-2454.e6. doi: 10.1016/j.joms.2018.07.013. Epub 2018 Jul 20. J Oral Maxillofac Surg. 2018. PMID: 30107162 Review.
Cited by
-
The Nexus of Hyperparathyroidism and Thyroid Carcinoma: Insights into Pathogenesis and Diagnostic Challenges-A Narrative Review.J Clin Med. 2023 Dec 27;13(1):147. doi: 10.3390/jcm13010147. J Clin Med. 2023. PMID: 38202152 Free PMC article. Review.
-
Primary Hyperparathyroidism with Thyroid Cancer: Clinicopathologic Features.Sisli Etfal Hastan Tip Bul. 2022 Jun 28;56(2):250-255. doi: 10.14744/SEMB.2022.36418. eCollection 2022. Sisli Etfal Hastan Tip Bul. 2022. PMID: 35990290 Free PMC article.
-
Navigating diagnostic dilemmas: Localizing parathyroid adenoma in the presence of MIBI-avid thyroid nodules: A case report and literature review.Radiol Case Rep. 2024 Nov 26;20(2):1041-1046. doi: 10.1016/j.radcr.2024.08.102. eCollection 2025 Feb. Radiol Case Rep. 2024. PMID: 39678721 Free PMC article.
-
Increased thyroid malignancy in patients with primary hyperparathyroidism.Endocr Connect. 2021 Aug 2;10(8):885-893. doi: 10.1530/EC-21-0217. Endocr Connect. 2021. PMID: 34261038 Free PMC article.
References
-
- Fau OP, Black BM. Primary hyperparathyroidism and papillary adenocarcinoma of the thyroid; report of four cases. 1956. - PubMed
-
- Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid Cancer. Thyroid. 2015;2015:1557–9077. - PMC - PubMed
-
- Aşik M, Anaforoǧlu I, Köse M, Karyagar S, Mollamehmetoǧlu B, Algün E. Papillary thyroid carcinoma with primary hyperparathyroidism: a report of two cases and a brief literature review. Turkish J Endocrinol Metab. 2013;17(1):12–14. doi: 10.4274/Tjem.2237. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical